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Free-living amoebae cause three well-defined disease entities: a rapidly fatal primary me-
ningoencephalitis, a chronic granulomatous amoebic encephalitis (GAE), and a chronic amoe-
bic keratitis. GAE occurs in immunocompromised persons. Recently, another type of free-
living amoeba, Balamuthia mandrillaris, has been shown to cause GAE. The finding that this
amoeba has caused infection in some healthy children has raised the possibility that humans
may lack immunity to B. mandrillaris. Human serum was examined for the presence of surface
antibodies specific for this amoeba by immunofluorescence. Sera from adults contained titers
of 1/64–1/256 of anti–B. mandrillaris antibodies (IgM and IgG classes), which did not cross-
react with other amoebae. Cord blood contained very low antibody levels, but levels similar
to those in adults were seen in serum of 1- to 5-year-old children.
Since the original postulation by Fowler and Carter in 1965
[1] that free-living amoebae present in soil and water were re-
sponsible for a rapidly fatal meningoencephalitis in children in
South Australia, there have been worldwide reports of fatal
cases of this disease and diseases caused by other types of free-
living amoebae. Naegleria fowleri was named as the agent re-
sponsible for the rapidly fatal primary amoebic meningoen-
cephalitis [2]. Acanthamoeba species cause two other
well-de®ned disease entities. They are responsible for the de-
velopment of a granulomatous amoebic encephalitis (GAE)
and a chronic amoebic keratitis [2].
In its life cycle, N. fowleri displays cyst, trophozoite, and
transient ¯agellate stages. The persistence of speci®c stages de-
pends on temperature, nutrients, and salt concentrations in the
environment. The trophozoite stage is the infective form of this
amoeba, as it is for Acanthamoeba species which do not have
a ¯agellate stage. N. fowleri and Acanthamoeba species are ubiq-
uitous in nature (e.g., N. fowleri has been isolated worldwide
from a variety of sources, such as public water supplies, swim-
ming pools, freshwater lakes, and thermally polluted waters).
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Most cases of Naegleria meningoencephalitis involve children
with a history of swimming in public pools or freshwater lakes
[2]. The organism invades via the olfactory neuroepithelium,
directly entering the central nervous system (CNS), where the
amoebae cause rapid destruction of the olfactory bulbs and a
widespread meningitis and hemorrhagic, necrotizing encepha-
litis. In contrast, Acanthamoeba species usually invade the CNS
by a hematogenous spread, producing a GAE. Invasion of the
CNS follows the establishment of the organism in primary sites,
such as the skin, eyes, and respiratory tract [2]. Patients exhib-
iting GAE do not have an associated history of swimming, are
usually either debilitated and chronically ill or undergoing im-
munosuppressive therapy, or are patients with AIDS [2]. In
contrast, chronic keratitis due to Acanthamoeba species occurs
in healthy individuals who may have experienced minor trauma
to the eye or who wear soft contact lenses [2].
In the community, naturally acquired immunity to Naegleria
and Acanthamoeba species plays an important role in restricting
the number of cases of primary amoebic meningoencephalitis
and GAE [3]. Naegleria species does not spread hematogen-
ously [1, 3] and has a restricted invasion route. In contrast,
Acanthamoeba species spreads hematogenously, owing mainly
to a depressed defense system [2, 3]. A number of the com-
ponents of the immune system are responsible for the immunity
displayed against these organisms. These include the ability of
the amoebae to activate complement through the alternative
pathway (not requiring antibody), the ability of neutrophils and
macrophages to kill the amoebae, and the presence of anti-
bodies against these amoebae [4±8].
Another free-living amoeba, Balamuthia mandrillaris, was
discovered recently and has been shown to cause a fatal GAE
[2, 9]. Of interest, many cases previously diagnosed as GAE
have now been retrospectively characterized as granulomatous
Balamuthia encephalitis [2]. Although it has been assumed that
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Balamuthia species, like Acanthamoeba species, infect only im-
munocompromised persons (including AIDS patients), infec-
tion with this amoeba of 2 US children [10] and 2 Australian
children [11, 12] possessing apparently normal immunity in-
dicates that Balamuthia species may be more virulent than
Acanthamoeba species.
The question of virulence is a crucial one since infections
caused by B. mandrillaris are believed to also occur in healthy
children; thus, this organism is of great concern to our com-
munity. Not only do we not know the environmental distri-
bution of the organism, but very little is known about natural
host defenses against the amoeba. Knowledge as to whether
we possess ªnaturalº immunity to Balamuthia species will be
of major importance in the education of parents and the com-
munity regarding the dangers of this amoeba.
Materials and Methods
Serum samples were randomly collected from healthy adult vol-
unteers. In addition, serum samples were available from 1- to 5-
year-old children who had undergone testing for immunoglobulin
de®ciency and were found to be normal. These subjects were all
South Australian residents. Umbilical cord blood was collected as
the source of neonatal serum.
B. mandrillaris (leptomyxida ameba: CDC, V039), which was
isolated from the brain of a mandrill baboon [9], was obtained
from F. L. Schuster (Brooklyn College, Brooklyn, NY) [13]. This
species has been well characterized, grown axenically, and used to
raise antisera for diagnosing human cases of B. mandrillaris me-
ningoencephalitis [9]. The amoeba was cultured axenically accord-
ing to the method of Schuster and Visvesvara [13]. In brief, B.
mandrillaris was maintained in growth medium containing biosate
peptone (Becton Dickinson Microbiology Systems, Cockeysville,
MD), yeast extract (Sigma, St. Louis), Torula yeast RNA (Sigma),
and ox liver extract (Oxoid, Hampshire, UK) supplemented with
10% fetal calf serum for 5±7 days. When cultures reached con¯u-
ence, they were chilled on ice for 5±10 min to detach the amoebae.
After three washes with Hanks' balanced salt solution (HBSS), the
amoebae were ®xed with 1% formaldehyde and stored at 47C for
use in experiments. N. fowleri and Acanthamoeba culbertsoni were
similarly cultured in Fulton's medium A supplemented with 10%
fetal calf serum and trypticase soy broth as described previously
[4, 5].
For immuno¯uorescence staining to detect anti±Balamuthia an-
tibodies, the amoebae were incubated with serum at different di-
lutions for 1 h at 47C, as indicated in the results [14, 15]. The cells
were washed, and 50 mL of ¯uorescein isothiocyanate (FITC)±
labeled anti-human immunoglobulin (IgG1IgA1IgM) antisera
(1/20 dilution; Behring, Marburg, Germany) was added. To ex-
amine for antibody class, we added 10 mL of FITC-labeled anti-
human IgM monoclonal antibodies (PharMingen, San Diego) or
10 mL of phycoerythrin-labeled anti-human IgG monoclonal an-
tibodies (PharMingen) for 1 h at 47C. After incubation, the cells
were washed and ®xed with 1% formaldehyde±Isoton II (Coulter
Electronics, New South Wales, Australia) solution. Anti-amoeba
antibodies were quanti®ed by ¯ow cytometry (FACScan with Lysis
II software; Becton Dickinson Immunocytometry Systems, Moun-
tain View, CA). In addition, the cell preparations were added to
microscope slides in liquid phase and examined by use of a ¯uo-
rescence microscope.
Results
Human serum contained anti±Balamuthia antibodies, as de-
termined by the indirect immuno¯uorescence test. When the
amoebae were viewed with a microscope under UV light, in-
tense surface staining was evident (data not presented). Initial
studies demonstrated that the amount of ¯uorescence could be
quantitated by ¯ow cytometry analysis. Flow cytometry of 50
serum samples from adults showed that all contained
anti±Balamuthia antibodies but with different levels of activity
(data not presented). The titer ranged from 1/64±1/256, and the
antibodies were IgM and IgG types. Placental transfer of
anti±Balamuthia antibodies was evident from the presence of
these antibodies in cord blood (®gure 1). However, the levels
were much lower than those in adult serum (titer of <1/4; ®gure
1). The anti±Balamuthia antibody levels in sera from the group
of 1- to 5-year-old children were similar to those in sera from
the adults (®gure 1).
To determine whether the antibodies against B. mandrillaris
were speci®c for this amoeba or cross-reactive with Naegleria
or Acanthamoeba species, we examined the effects of serum
adsorption with either of these amoeba on the serum titer of
the anti±Balamuthia antibodies. B. mandrillaris (1 mL) was
mixed with either N. fowleri ( ), A. culbertsoni ( ),7 72 3 10 2 3 10
or HBSS at 47C for 4 h, and the amoebae were removed by
centrifugation. This adsorbed serum was then tested for the
presence of antibodies to the 3 types of amoebae. Serum ad-
sorbed with either N. fowleri or A. culbertsoni retained amounts
of anti±Balamuthia antibodies equivalent to those of the non-
adsorbed serum (table 1); however, the adsorbed serum had
lost 198% of the antibodies to either Naegleria or Acanthamoe-
ba species (table 1). When human serum was adsorbed with
B. mandrillaris (at one-half dilution), 89% of the anti±B.72 3 10
mandrillaris antibody activity was lost. This showed that the
antibodies binding to B. mandrillaris were speci®c for this
amoeba.
Discussion
The ability of amoebae that freely live in soil and fresh water
to cause disease in humans is of major concern to the com-
munity, particularly as there is no effective treatment of CNS
infection caused by these organisms, and infection is invariably
fatal. We now present evidence that human serum contains
antibodies to another type of amoeba, B. mandrillaris, that was
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Figure 1. Levels of antibodies to Balamuthia mandrillaris in serum
from adults, neonates, 1- to 3-year-old children (1±3Y), and 3- to 5-
year-old children (3±5Y) as total immunoglobulin (Ig) and IgG and
IgM classes. Serum was analyzed by indirect immuno¯uorescence tech-
nique, using ¯ow cytometry at one-fourth serum dilution. Levels for
adults and neonates were compared by use of Wilcoxon's signed rank
test: * ; ** .P ! .05 P ! .01
Table 1. Serum anti-Balamuthia antibody levels after adsorption with
other pathogenic free-living amoebae.
Serum treatmenta
Antibody titers to
B. madrillaris N. fowleri A. culbertsoni
Nonadsorbed 1/256 1/64 1/256
A. culbertsoni±adsorbed 1/256 ND !1/4
N. fowleri±adsorbed 1/256 !1/4 ND
NOTE. done.ND 5 not
a Serum was adsorbed with Acanthamoeba culbertsoni or Naegleria fowleri and
then tested for antibody levels to Balamuthia madrillaris, A. culbertsoni, and N.
fowleri by indirect immuno¯uorescence assay and ¯ow cytometry.
recently shown to be responsible for a GAE. This amoeba is
believed to invade the CNS secondary to the colonization of
primary sites, such as the skin, and invasion of the CNS follows
the hematogenous spread of the amoeba. In many cases, suc-
cessful invasion has been associated with immunosuppression
in the infected individual. Previous studies with N. fowleri and
Acanthamoeba species have shown that immunity to these spe-
cies results from the collaborative action of phagocytic cells
and antibody [3]. It is likely that the antibodies to B. mandril-
laris also play an opsonization role. Preliminary studies have
shown that unlike Naegleria and Acanthamoeba species, B.
mandrillaris was not killed (lysed) by human serum, although
this serum did promote adherence of neutrophils to the amoeba.
It would be interesting to compare the ability of sera to promote
neutrophil-mediated killing of the amoeba.
Any invasion from primary sites probably requires some de-
pression of immunoglobulin levels or decreased phagocytic cell
function (or both). The reasons why young, healthy children
contracted Balamuthia infections that developed into a GAE
remain unclear [10±12], but in one case, the child exhibited
facial lesions that were colonized by the organism [12]. An
examination of the serum of these patients for levels of anti±
Balamuthia antibodies might provide some insight. However,
initial studies with serum from our patient [11] who died of
B. mandrillaris GAE showed an increase in antibody titer of
1/1024 ( /64; /1024). This is a 4-fold increase inIgM 5 1 IgG 5 1
antibody titer relative to the titer found in control children of
similar age, suggesting that the child responded to the amoeba
antigens. Whether this represents a protective response or not
remains to be established. The rise in the titer, which is well
above the range in noninfected children, could provide a means
of diagnosing the disease.
Similar to the previous ®ndings with Acanthamoeba and Nae-
gleria species, anti–Balamuthia antibodies were present in the
IgM and IgG classes [15]. The serum was also found to be
opsonic in attracting neutrophils to bind to B. mandrillaris and
killing the amoeba (data not presented); this ®nding could be
explored as another marker of immunocompetence. Of interest,
the antibodies to this amoeba were speci®c because they could
be adsorbed by B. mandrillaris but not Naegleria or Acanth-
amoeba species. Since the antibody levels were very low in neo-
nates, the ®ndings suggest that these levels substantially increase
with age, probably as a result of environmental exposure to the
amoeba in the soil.
The present studies were done with a B. mandrillaris isolate
that was recovered from a baboon that died from GAE [9].
The isolate is the most characterized isolate, which led to the
discovery that it causes human GAE and can successfully be
cultured axenically. Indeed, antisera raised against this isolate
have been used to diagnose human cases of B. mandrillaris GAE
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[9]. It is therefore unlikely that our ®ndings are not represen-
tative of human isolates. Our studies have also been con®ned
to the sera of residents of South Australia; studies on sera from
a wider international community may add further knowledge
to our understanding of natural immunity to B. mandrillaris.
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